IMRAN MIR A 4
4 · Rani Therapeutics Holdings, Inc. · Filed Dec 17, 2024
Insider Transaction Report
Form 4
IMRAN MIR A
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-12-16−101,276→ 0 totalExercise: $2.84From: 2024-05-25Exp: 2033-05-24→ Class A Common Stock (101,276 underlying) - Award
Stock Option (Right to Buy)
2024-12-16+101,276→ 101,276 totalExercise: $4.11From: 2024-05-25Exp: 2033-05-24→ Class A Common Stock (101,276 underlying)
Footnotes (1)
- [F1]On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.